AVOIVE PLLA
| Composition | PLLA 150 mg, SCMC 50 mg |
| Indications | Natural Filling, Skin Rejuvenation, Improvement of Deep Wrinkles |
| Duration | 24 months |
| Method | Direct Injection or MTS (Meso Injector, Meso Roller) |
| Packing Unit | 200 mg x 1 vial |
AVOIVE PLA
| Composition | PLA 150 mg, HA 50 mg |
| Indications | Natural Filling, Skin Rejuvenation, Improvement of Deep Wrinkles |
| Duration | 12 months |
| Method | Direct Injection or MTS (Meso Injector, Meso Roller) |
| Packing Unit | 200 mg x 1 vial |
AVOIVE PLGA
| Composition | PLGA 150 mg, HA 50 mg |
| Indications | Natural Filling, Skin Rejuvenation, Improvement of Deep Wrinkles |
| Duration | 06 months |
| Method | Direct Injection or MTS (Meso Injector, Meso Roller) |
| Packing Unit | 200 mg x 1 vial |
AVOVELLA
| Composition | PLLA, CMC, Mannitol |
| Indications | Natural Filling, Skin Rejuvenation, Improvement of Deep Wrinkles |
| Duration | 24 months |
| Method | Direct Injection or MTS (Meso Injector, Meso Roller) |
| Packing Unit | 1.8 mL x 1 vial |
AVOIVE PLLA
Composition PLLA 150 mg, SCMC 50 mg |
Indications Natural Filling, Skin Rejuvenation, Improvement of Deep Wrinkles |
Duration 24 months |
Packing Unit 200 mg x 1 vial |
AVOIVE PLA
Composition PLA 150 mg, HA 50 mg |
Indications Natural Filling, Skin Rejuvenation, Improvement of Deep Wrinkles |
Duration 12 months |
Packing Unit 200 mg x 1 vial |
AVOIVE PLGA
Composition PLGA 150 mg, HA 50 mg |
Indications Natural Filling, Skin Rejuvenation, Improvement of Deep Wrinkles |
Duration 06 months |
Packing Unit 200 mg x 1 vial |
AVOVELLA
Composition PLLA, CMC, Mannitol |
Indications Natural Filling, Skin Rejuvenation, Improvement of Deep Wrinkles |
Duration 06 months |
Packing Unit 1.8 mL x 1 vial |
